ORCHESTRA THERAPEUTICS Pages on BioPortfolio:

BioPortfolio - ORCHESTRA THERAPEUTICS
ORCHESTRA THERAPEUTICS - BioPortfolio. ... BioPortfolio - Orchestra Therapeutics Orchestra Therapeutics - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/_ORCHESTRA_THERAPEUTICS_....

BioPortfolio - orbus life sciences
Orbus Life Sciences Inc. Orbus Pharma Inc. Orchestra Therapeutics · Orchid Chemicals & Pharmaceuticals Ltd. Ore Pharmaceuticals Inc. . ...
http://www.bioportfolio.com/search/orbus_life_sciences.html...

BioPortfolio orchestra therapuetics
Orchestra Therapeutics Entry on Bioportfolio's Biocorporate Database ... Peptide Vaccines and MBPBase Therapeutics Orchestra Therapeutics BioMS MedicalEli ...
http://www.bioportfolio.com/search/orchestra_therapuetics.ht...

BioPortfolio Orchestra Therapeutics Profile
View the current Orchestra Therapeutics Page on BioPortfoliocom. httpwwwbioportfoliocombiocorporate5263Orchestra+Therapeuticshtml. Contact Details ...
http://www.bioportfolio.com/biocorporate/5263-Orchestra+Ther...

INFLAMMATORY DIRECTIONS Strategies for Six Diseases with Unmet Needs
Peptide Vaccines and MBP-Base Therapeutics Orchestra Therapeutics BioMS Medical/Eli Lilly Bayhill Therapeutics Remyelinating Agents Biogen Idec ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_207.html...

BioPortfolio - Biocorporate Search
Orchestra Therapeutics’ unique approach to controlling autoimmune diseases uses small peptide vaccines that appear to stimulate FOXP3+ Regulatory T-cells; ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

Multiple Sclerosis Market Analysis & Forecasts Report 2007-2022
Orchestra Therapeutics Otsuka Pepgen Pfizer Pipex Protein Design Labs ReceptoPharm Régime Social des Indépendants (RSI) Roche S. Andrea Hospital ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_176.html...

Results from other life science and pharmaceutical sites:

Orchestra Therapeutics Announces New Trading Symbol
"This marks an exciting moment in the Company's history as Orchestra Therapeutics transforms itself into an innovative and dynamic company grounded in the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

BioMed Central | Full text | The future of toll-like receptor ...
Orchestra Therapeutics Inc (formerly The Immune Response Corp) was evaluating an HIV vaccine IR-103 comprising Remune and a TLR9 agonist adjuvant, Amplivax, ...
http://www.biomedcentral.com/1464-8431/10/21...

The Immune Response Corporation
07:00 ET, Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax(TM) Demonstrating Marked Expansion of Regulatory T Cell Populations in ...
http://www.prnewswire.com/comp/434675.html...

Table 1 : Antigen-specific tolerance strategies for the prevention ...
TCR vaccination, MS, Phase I and II clinical trial of trivalent TCR peptide vaccine IR903 (Neurovax; Orchestra Therapeutics), Induced specific TCR-reactive ...
http://www.nature.com/nri/journal/v7/n9/fig_tab/nri2153_T1.h...

BioScan : O
Onconova Therapeutics Inc. Ono Pharmaceutical Co. Ltd. ... Orchestra Therapeutics Inc. Orchid Cellmark Inc. Orexigen Therapeutics Inc. ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.